Michael joined Medicines Discovery Catapult as an intern at the start of 2019 at the end of his PhD in Oncology at Oxford University.
Michael stayed at MDC to volunteer at the Lighthouse COVID test labs at the start of the pandemic and then joined MDC as a senior scientist in spatial biomarkers. Now he applies spatial proteomic and transcriptomic techniques on a wide range of tissues and diseases.
